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Activin has long-range effects in Xenopus development,
inducing the mesodermally expressed brachyury gene
up to 10 cell diameters from a localised source. Recent
experiments show that activin diffuses through tissues
to establish a morphogen gradient, and that the long-
range effects are a direct result of activin signalling.
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The notion that, in development, certain molecules act
as ‘morphogens’ was postulated well before any specific
morphogen was identified. The idea is that a morphogen
diffuses so as to establish a concentration gradient across
a developmental field, within which cells respond to pre-
determined thresholds of the molecule by adopting par-
ticular fates and/or cell behaviours [1]. A molecule sug-
gested to act as a morphogen in vertebrate development is
the mesoderm-inducing factor activin, a member of the
transforming growth factor β (TGF-β) superfamily of
secreted growth factors. In amphibians, mesoderm is
formed in the equatorial marginal zone of the blastula — an
early embryonic stage with 32–5000 cells — as a result of
inductive signals released by the vegetal hemisphere. This
can be shown experimentally by conjugating animal ‘caps’
(see Figure 1) and vegetal ‘poles’ isolated from opposite
ends of mid-blastula stage embryos; in isolation, these two
ends of the embryo differentiate as epidermis and endo-
derm, respectively, but when combined, the animal cap also
differentiates as mesoderm [2]. Over the last 10 years,
mesoderm-inducing factors, including activin, have been
identified that mimic the action of the vegetal pole.
Evidence that activin can act as a morphogen was first
provided by Green and Smith [3], who showed that
increasing the activin concentration diverted dissociated
animal cap cells from their normal epidermal fate
towards progressively more dorsal mesodermal fates.
These experiments were extended by Gurdon and his
colleagues [4], who conjugated animal caps to an artificial
source of activin — a second animal cap previously
injected with activin RNA or a bead containing activin
protein. They used in situ hybridisation to analyse the
expression domains of Xgoosecoid (Xgsc) and Xbrachyury
(Xbra), two genes that are activated by high and low con-
centrations of activin, respectively. When high concen-
trations of activin were used, Xgsc was expressed in cells
adjacent to the source, whereas Xbra was expressed at a
much greater distance — up to 300 µm or approximately
10 cell diameters from the source (Figure 1). At lower
activin concentrations, expression of Xgsc could not be
detected and Xbra was now expressed by cells adjacent
to the source. 
The simplest interpretation of these results is that a
concentration gradient of activin is established in the
responding tissue (Figure 2a), but no direct evidence for
this gradient was obtained and some workers have ques-
tioned the validity of these conclusions. An alternative
explanation for these results is that the long-range effects
of activin are mediated by a relay of short-range signals.
For example, activin may diffuse over a short-range to
induce expression of Xgsc, but a second signal released by
these Xgsc-expressing cells is responsible for inducing
expression of Xbra in adjacent cells (Figure 2b). Evidence
against long-range diffusion of activin was provided by
Reilly and Melton [5], who used antibodies to show that
activin could not be detected outside the source. 
Reilly and Melton [5] also performed an elegant experi-
ment in which different cells were injected with mRNAs
for either TGF-β or its receptor TGFβIIR. TGF-β does
not induce mesoderm when expressed alone in animal
caps, yet induces the full-range of mesodermal tissue
types when coexpressed with its receptor. This means that
cells expressing TGF-β can be separated from cells
expressing its receptor by a barrier of non-responsive cells.
Figure 1
Experiments to test whether activin can act as a morphogen [4] have
used animal cap conjugates, in which activin-coated beads were
sandwiched between two animal caps isolated from Xenopus mid-
blastulae, and incubated until early gastrula stages. Adjacent sections
were then analysed by in situ hybridisation for either Xgsc (blue) or
Xbra (red) expression. When high concentrations of activin were used,
Xgsc was expressed by cells in close proximity to the beads, whereas








They found that Xbra was only induced when ligand-
expressing and receptor-expressing cells were in direct
contact, suggesting that TGF-β can only act over a short-
range. Lastly, they coinjected mRNAs for TGF-β and
TGFβIIR and showed that uninjected cells could differ-
entiate as muscle; as these cells did not express TGFβIIR,
they could not be responding to TGF-β directly. Reilly
and Melton [5] concluded that members of the TGF-β
family act over a short range in early Xenopus embryos, and
that the observed long-range effects are mediated by
secondary signals.
Two recent papers [6,7], however, have provided evi-
dence that activin can indeed act as a morphogen and does
not initiate a cell–cell signalling relay in Xenopus tissues.
In the first study, Jones et al. [6] injected mRNA for a con-
stitutively active form of the activin receptor, and showed
that it induced expression of both Xgsc and Xbra in a
strictly cell-autonomous manner in conjugated animal
caps. If activin were initiating a relay of short-range
signals, then this relay should also have been initiated by
this activated receptor and the induction of Xgsc and Xbra
should not have been cell-autonomous.
In the second study, McDowell et al. [7] made use of
dominant-inhibitory forms of the activin receptor to show
that even the most distant responses require a functional
activin signalling pathway. For example, they made conju-
gates in which an intervening layer of labelled animal cap
cells was sandwiched between activin-coated beads and
an animal cap expressing a dominant-inhibitory activin
receptor. In situ hybridisation showed that, whereas the
intervening layer of cells, and the lower control layer,
expressed Xbra, more distant cells bearing the dominant-
inhibitory receptors did not. If the long-range effects of
activin were mediated by a second signal, then this signal
should have induced Xbra expression in these distant
cells. The fact that Xbra was not induced argues that
activin has a direct effect on the distant cells. 
McDowell et al. [7] also obtained direct evidence that
activin can diffuse through solid tissue. They conjugated
animal caps to beads coated in radiolabelled activin and,
after a few hours, sectioned the conjugates and observed
the distribution of radiolabelled activin by autoradiogra-
phy. They found that activin had formed a concentration
gradient within the animal cap, diffusing at least 120 µM
— approximately seven cell diameters — away from the
source. The difference between this result and those of
Reilly and Melton [5] probably reflects the increased sen-
sitivity of radiolabelling compared to antibody staining,
and the use of activin-coated beads rather than activin
mRNA injection.
McDowell et al. [7] have also shown that TGF-β can
diffuse through solid tissue. They made conjugates in
which an intervening layer of labelled animal cap cells was
sandwiched between TGF-β-coated beads and an animal
cap expressing TGFβIIR. As animal caps do not express
functional TGF-β receptors, the intervening layer cannot
respond to TGF-β by producing a secondary signal. In situ
hybridisation showed that Xbra was expressed by distal
TGFβIIR-injected cells, indicating that TGF-β had dif-
fused through the intervening layer. But how are we to
explain the difference between these results and those of
Reilly and Melton [5], who obtained evidence that TGF-β
cannot diffuse through solid tissue? 
One difference between the two sets of experiments is that
McDowell et al. [7] used protein-coated beads, whereas
Reilly and Melton [5] injected TGF-β mRNA. To see if
this was significant, McDowell et al. [7] made conjugates
between animal caps injected with TGF-β mRNA and
animal caps injected with TGFβIIR. In agreement with
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Figure 2
Models for long-range signalling by activin. 
(a) Morphogen gradient. In this model, activin
diffuses throughout the layer of cells and
forms a concentration gradient, with high
levels close to the source and low levels
distally. At the lowest levels of activin, cells
differentiate as epidermis (yellow cells), but
above a prespecified concentration (threshold
1) they activate expression of Xbra (red cells).
As the concentration increases, a second
prespecified value (threshold 2) is reached,
and cells activate expression of Xgsc (blue
cells). While this same threshold value may
also repress Xbra, it is also possible that Xbra
is repressed by Xgsc. (b) Signal relay. There
are many variants of this model but, in the one
illustrated here, activin (signal 1) diffuses over
a short range and induces Xgsc; activin also
causes a second signal to be released (signal
2), which also acts over a short range to
induce Xbra in adjacent cells. The essential
element in this model is that Xbra is not
induced by activin directly, but by a secondary
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Reilly and Melton [5], they found that injected TGF-β only
had short-range effects. One explanation for these results is
that TGF-β is processed and/or secreted inefficiently by
injected Xenopus cells, such that there is insufficient protein
to act over a long range. This is a plausible explanation for
TGF-β, as there is evidence that efficient secretion of this
protein requires additional proteins that may not be present
at sufficient concentrations in animal caps [8].
Reilly and Melton [5] also showed that cells expressing
both TGF-β and its receptor can recruit uninjected cells to
differentiate as muscle. As uninjected cells cannot respond
to TGF-β directly, this is good evidence for a second signal.
We can reconcile these results with those of McDowell et al.
[7] by assuming that this signal is a relatively late response
to TGF-β signalling. McDowell et al. [7] analysed their
experiments at early gastrula stages, assaying for Xbra and
Xgsc mRNAs, which are early responses to activin and
TGF-β signalling. In contrast, Reilly and Melton [5]
analysed their experiment two days later, at stage 35, and
assayed muscle differentiation, which is a late response to
activin signalling. This suggests that the second signal may
also be a late response to TGFβ signalling, early responses
being mediated by a morphogen gradient.
Taken together, these results provide compelling evidence
that members of the TGF-β family can diffuse through
solid tissue and signal directly over a long range, although
secondary signals may also play a role at later stages. As
members of the TGF-β family have been implicated as sig-
nalling molecules in a large number of developmental
processes in many different organisms, as well as in bone
remodelling, wound healing and neuronal plasticity in
adults, the results of these studies may be widely applicable
[9]. However, there is still no direct evidence that these
molecules form morphogen gradients in the embryo,
reflecting the fact that they are active at concentrations
below the limits of detection by current techniques. 
In early Xenopus gastrulae, Xgsc and Xbra are both
expressed in the dorsal marginal zone, where they have
expression patterns resembling those induced in animal
caps by activin. Xgsc is expressed in a band of cells close
to the vegetal hemisphere, the presumed source of the
inducing signal, whereas Xbra is expressed more distally
[4]. This is exactly what one would expect if these genes
were regulated by a morphogen released by the vegetal
hemisphere. Studies on the Xgsc promoter, however,
have shown that at least two signals are required for Xgsc
expression in the embryo [10]. One of these is an activin-
like signal that is active throughout the vegetal hemi-
sphere, and the second may be a Wnt-like signal localised
to the dorsal quadrant of the embryo. This indicates that,
in the embryo, the expression pattern of Xgsc is regulated
by a combination of signals, rather than a simple mor-
phogen gradient.
Finally, while there is good evidence that a member of the
TGF-β family is required for mesoderm induction in
Xenopus, it is still a matter of conjecture whether activin
itself is involved [11,12]. Although not without problems,
the most likely candidate for being an endogenous meso-
derm-inducing factor is Vg1, and it would be interesting to
know if this molecule has long-range and/or short-range
signalling properties. What the experiments of McDowell
et al. [7] tell us is that we can only ascertain this by using
purified protein.
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